(Q28222356)

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Molecular circuits of resolution: formation and actions of resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Resolvin D series and protectin D1 mitigate acute kidney injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Resolution of inflammation: the beginning programs the end

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipid mediator class switching during acute inflammation: signals in resolution.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Resolution of inflammation: state of the art, definitions and terms

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

COX-2 in inflammation and resolution

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Pathogenesis of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Neutrophil-derived leukotriene B4 is required for inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxin A4Analogues Inhibit Leukocyte Recruitment toPorphyromonas gingivalis: A Role for Cyclooxygenase-2 and Lipoxins in Periodontal Disease†

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-Mediator lipidomic analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Prostaglandins and their regulation in rheumatoid inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Inter-relationships between rheumatoid arthritis and periodontal disease. A review.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Tumour necrosis factor alpha blockade and the risk of vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0616

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0616

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17906612

1 reference

Consolidated OpenCitations Corpus – April 2017